JNCI Podcast Episodes 2011
Journal of the National Cancer Institute now provides free podcasts of each published issue, keeping you in touch with the latest research on your computer or on the go.
If you are having problems subscribing or listening please visit our Podcast Page
Listen to or download individual episodes
You can also listen to individual episodes directly on your browser by selecting the episode link below.
- Dr. Chantal Quinten discusses her involvement in a study designed to measure if patient-self reporting could compliment clinician-reported data to attain more reliable measurements of clinical outcomes.
(4th January 2012)
- Dr. Michael Gnant of the Medical University of Vienna discusses data showing positive results on zoledronic acid and endocrine therapy for premenopausal breast cancer patients at the San Antonio Breast Cancer Symposium held Dec. 6-10.
(15th December 2011)
- Summary of Volume 103 Issue 24.
(13th December 2011)
- Summary of Volume 103 Issue 23.
(22nd November 2011)
- Dr. Douglas McNeel discusses early stage studies on DNA vaccines for castrate resistant prostate cancer ahead of his presentation of the study results at the Society for Immunotherapy of Cancer annual meeting in Bethesda, held Nov. 4-6.
(14th November 2011)
- Summaries of the New Stories from Volume 103 Issue 21
(21st October 2011)
- Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction
(21st October 2011)
- Dr. Chris Parker, lead investigator of the international ALSYMPCA trial of radium 223 (Alpharadin) for bone metastases in advanced prostate cancer, discusses the trial and future of this therapy following his lecture at the recent ECCO-ESMO Cancer Congress in Stockholm.
(12th October 2011)
- Dr. Gordon Mills elaborates on his lecture on molecular personalized medicine at the recent ECCO-ESMO Cancer Congress in Stockholm.
(12th October 2011)
- Dr. Eduardo Franco discusses a study showing that one and two doses of HPV vaccines are just as effective as three doses for decreasing the risk of cervical cancer.
(9th September 2011)
- Issue 18: News Summaries
(16th September 2011)
- Dr. Kathy Helzlsouer, of the Prevention and Research Center at Mercy Medical Center in Baltimore, discusses breast cancer risk prediction models based on findings from a study of a cohort of Italian women. (26th July 2011)
- Dr. Jennifer Vidrine, of the University of Texas MD Anderson Cancer Center, discusses active and passive recruitment methods for smoking quitlines. (10th July 2011)
- Dr. Joan Warren, of the National Cancer Institute, conducted a study that compared end-of-life care for lung cancer patients in Ontario and the U.S. (8th June 2011)
- Dr. Judy Garber, of the Dana Farber Cancer Institute in Boston, discusses how family cancer history should be integrated into personalized patient care. (11th May 2011)
- Dr. Lisa Kachnic, of Boston University Medical Center, discusses how the growing usage of IMRT, or intensity-modulated radiation therapy, for breast cancer is mostly taking place in parts of the country where the procedure is reimbursed. (28th April 2011)
- Annual Report to the Nation: Dr. Brenda Edwards, one of the authors of the Annual Report to the Nation on cancer trends in the U.S., discusses this year's report, which focuses on brain tumors. The Report showed an overall decline in cancer mortality rates. (31st March 2011)
- PSA Velocity and Prostate Cancer Screening: Dr. Otis Brawley discusses a study on PSA velocity showing that using PSA velocity as a prostate cancer marker would not improve patient outcomes and would lead to a large number of unnecessary biopsies (24th February 2011)
- JNCI interview: Dr. Philip Castle discusses HPV DNA testing. (26th January 2011)
- JNCI interview: Dr. Patricia Ganz of UCLA discusses a review of breast cancer clinical trials that included quality of life measures as endpoints. (29th December 2010)
Other Podcast Episodes
- About this journal
- Contact Us
- Rights & Permissions
- Dispatch date of next issue
- This journal is a member of the Committee on Publication Ethics (COPE)
- We are mobile – find out more
Carmen J. Allegra
Impact factor: 14.336
5-Yr impact factor: 14.794
For the Media
Open access options for authors - visit Oxford Open